[ESPR] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 9.41%
YoY- -3.18%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 18,818 15,401 9,638 982 184,474 0 0 -
PBT -55,487 -65,119 -104,476 -61,946 -60,039 -37,891 -28,956 11.44%
Tax 12,974 13,430 8,795 5,165 -74 807 423 76.87%
NP -68,461 -65,119 -104,476 -61,946 -60,039 -37,891 -28,956 15.41%
Tax Rate - - - - - - - -
Total Cost 87,279 80,520 114,114 62,928 244,513 37,891 28,956 20.17%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -363.81 -422.82 -1,084.00 -6,308.15 -32.55 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.93 -1.77 -3.89 -2.26 -2.24 -1.44 -1.28 -5.18%
EPS Diluted -0.93 -1.77 -3.89 -2.26 -2.24 -1.44 -1.28 -5.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.